Furthermore, we found that the expression levels of CRABP2 in serous ovarian cancer was higher than in other types of ovarian cancer (Fig. 1H), which was confirmed by the HPA (Fig. S2C). Here, CRABP2 is linked to ovarian serous adenocarcinoma.